Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer

NCT02125019 is registered in ClinicalTrials.gov with Ohio State University Comprehensive Cancer Center as lead sponsor.

NCT NCT02125019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02125019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Evaluation of Taxane Induced Neuropathy in Early Stage Breast Cancer
Lead sponsor
Ohio State University Comprehensive Cancer Center
Phase
Observational
Overall status
Completed
Start date
December 4, 2013
Completion date
May 14, 2018
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer